VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
---|---|---|---|---|---|---|---|---|
TVIS10006400 | HBV | ENSG00000006071.16 | protein_coding | ABCC8 | No | No | 6833 | Q09428 |
TVIS10014476 | HBV | ENSG00000006071.16 | protein_coding | ABCC8 | No | No | 6833 | Q09428 |
TVIS20010586 | HPV | ENSG00000006071.16 | protein_coding | ABCC8 | No | No | 6833 | Q09428 |
TVIS44004571 | HTLV-1 | ENSG00000006071.16 | protein_coding | ABCC8 | No | No | 6833 | Q09428 |
TVIS44020396 | HTLV-1 | ENSG00000006071.16 | protein_coding | ABCC8 | No | No | 6833 | Q09428 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
Gene | ABCC8 |
---|---|
DrugBank ID | DB00839 |
Drug Name | Tolazamide |
Target ID | BE0008670 |
UniProt ID | Q14654 |
Regulation Type | blocker |
PubMed IDs | 8799949; 10354277 |
Citations | Szabo C, Salzman AL: Inhibition of ATP-activated potassium channels exerts pressor effects and improves survival in a rat model of severe hemorrhagic shock. Shock. 1996 Jun;5(6):391-4.@@Asano K, Cortes P, Garvin JL, Riser BL, Rodriguez-Barbero A, Szamosfalvi B, Yee J: Characterization of the rat mesangial cell type 2 sulfonylurea receptor. Kidney Int. 1999 Jun;55(6):2289-98. |
Groups | Approved; Investigational |
Direct Classification | Benzenesulfonamides |
SMILES | CC1=CC=C(C=C1)S(=O)(=O)NC(=O)NN1CCCCCC1 |
Pathways | |
PharmGKB | PA164774902 |
ChEMBL | CHEMBL817 |